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Abstract
The CD94/NKG2A heterodimer is a natural killer receptor (NKR), which inhibits cell-mediated
cytotoxicity upon interaction with MHC class I gene products. It is expressed by NK cells and by
a small fraction of activated CD8+ T lymphocytes. Abnormal upregulation of the CD94/NKG2A
inhibitory NKR on cytotoxic T cells (CTLs) could be responsible for a failure of
immunosurveillance in cancer or HIV infection. In this study, CD94/NKG2A receptor expression
on CD8+ T lymphocytes and NK cells was assessed in 46 HIV-1-infected patients (24 viraemic, 22
aviraemic) and 10 healthy volunteers. The percentage of CD8+ T lymphocytes expressing the
CD94/NKG2A inhibitory heterodimer was very significantly decreased in HIV-1-infected patients
in comparison with non-infected controls. Within the HIV infected patients, the proportion of
CD8+  T lymphocytes and NK cells expressing CD94/NKG2A was higher in subjects with
undetectable viral loads in comparison with their viraemic counterparts. No significant difference
was detected in the proportion of CD8+ T lymphocytes expressing the activatory CD94/NKG2C
heterodimer between the HIV-1 infected patients and the healthy donors, nor between the
vireamic and avireamic HIV-1 infected patients. In conclusion, chronic stimulation with HIV antigens
in viraemic patients leads to a decreased rather than increased CD94/NKG2A expression on CD8+
T lymphocytes and NK cells.
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Findings
The CD94/NKG2 heterodimer is a C-type lectin recep-
tor, formed by the covalent association of CD94, a pro-
tein with a short non-signaling intracytoplasmic tail
[1], and one of the NKG2 molecules. To generate a
functional receptor, CD94 is disulfide linked with a
member of the NKG2 family, namely NKG2A, -B, -C or
-E [2,3]. In humans, CD94/NKG2A interacts with com-
plexes of non-classical HLA-E molecules [4,5]. The
intracellular domain of NKG2A contains immunore-
ceptor tyrosine-based inhibition motifs (ITIMs),
responsible for transducing inhibitory signals [6]. The
other NKG2 members lack ITIMs and are linked to
transmembrane proteins, such as DAP10 and DAP12
which contain immunoreceptor tyrosine-based activat-
ing motifs and transduce activating signals [7]. CD94/
NKG2A is normally expressed on most NK cells and on
a small fraction of CD8+ T lymphocytes. The proportion
of NK cells bearing the CD94/NKG2A inhibitory recep-
tor decreases in advanced HIV infection [8], in contrast
with other inhibitory receptors of the KIR family which
are upregulated. It is presently unknown if HIV infec-
tion has similar effects on the expression of the CD94/
NKG2A inhibitory receptor by CD8+ T cells. A few stud-
ies have shown that CD94 expression by CD8+ T cells is
increased during HIV infection [9-11] and have led to
postulate that increased expression of the CD94/
NKG2A inhibitory receptors is one of the mechanisms
rendering HIV-specific CD8+ T lymphocytes unable to
control HIV-1 infection [12]. Nevertheless, the simulta-
neous expression of both subunits of the inhibitory
receptor on CD8+ T cells has hardly been studied in HIV
infection. Costa et al. using two-color FACS analysis to
study CD3+  NKG2A+  T cells, showed no difference
between uninfected controls, long term non progres-
sors or aviraemic subjects under HAART. A slight
increase was noted in subjects with active viral replica-
tion [13], in contradiction with the downregulation
previously observed on NK cells from infected subjects.
In the present study, we used four-colour FACS to inves-
tigate the expression of CD94/NKG2A and CD94/
NKG2C on CD3+ CD8+ T lymphocytes and NK cells
from HIV-1 infected patients, and its relationship with
HIV-1 viraemia. Immunostaining was performed with
fluorochrome-conjugated antibodies in 100 μl of
peripheral blood from HIV-1 infected patients. Partici-
pants included 46 HIV-1 infected patients (23 viraemic
and 23 aviraemic) and 10 healthy age-matched con-
trols. The cells were analyzed on FACSvantage with Cel-
lQuest software (BD Biosciences). Flow Cytometry
analysis was performed using fluorescence-conjugated
antibodies to CD3, CD8, CD56, CD94, NKG2A and
NKG2C. The Mann-Whitney test was used to compare
the proportion of cells expressing each heterodimer
between the three different groups of subjects (i.e. HIV
infected viraemic, aviraemic and non infected con-
trols). Figure 1 (1A, 1B and 1C) shows a representative
dot plot of the CD94/NKG2A expression by CD8+ T
lymphocytes and NK cells from healthy and HIV-1
infected controls (viraemic and aviraemic). There was a
dramatic decline in the proportion of CD8+ T cells
expressing the CD94/NKG2A heterodimer in HIV-
infected patients in comparison with uninfected con-
trols (mean ± SEM, 4.91 ± 0.49% n = 46 vs. 17.93 ±
3.26% n = 10 p < 0.0001) (Figure 1D). Interestingly, the
decrease of CD94/NKG2A expression was more pro-
nounced in patients with detected viral load than in
patients with less than 50 copies/ml (mean ± SEM, 4.15
± 0.65% n = 23 vs. 5.68 ± 0.7190 n = 23; p = 0.0379).
Similarly, the proportion of CD8+ T cells expressing the
CD94/NKG2C was lower in HIV infected patients than
in controls but the difference was not statistically sig-
nificant (mean ± SEM, 1.73 ± 0.59% n = 16 vs. 5.45 ±
2.25 % n = 10, p = 0.1626) (data not shown).
In HIV infected patients, there was a weak but significant
correlation between the proportion of CD8+  T lym-
phocytes and NK cells expressing the CD94/NKG2A het-
erodimer (r2 = 0,09184; p = 0.0406) and the proportion of
NK cells expressing the inhibitory receptor tended to be
lower in viraemic patients than in subjects with less than
50 copies/ml. (mean ± SEM, 43.11 ± 5.67% vs. 56.05 ±
4.67%; p = 0.019). There was no correlation of the expres-
sion of the inhibitory receptor with absolute or relative
CD4 counts (data not shown).
In summary, we observed a downregulation of CD94/
NKG2A on CD8+ T cells in HIV infection, in accordance
with what was previously described for NK cells. The
mechanisms linking viral replication with downregula-
tion of the inhibitory CD94/NKG2A receptor remains
obscure. Upregulation of CD94/NKG2A has previously
been observed in various animal models of viral and
bacterial infections [14] and in chronic antigenic stim-
ulation [15]. Loss of CD94/NKG2A might correspond
to the terminal differentiation which occurs in a large
fraction of CD8+ T cells during HIV infection. Indeed,
recent observations made in an experimental model of
persistent polyoma virus infections suggest that CD94/
NKG2A CD8+ T lymphocytes might constitute a less dif-
ferentiated subset of CD8+ T cells and maintain a higher
proliferative potential and capacity to secrete IL-2 [16].
Whatever is the mechanism involved, the loss of CD94/
NKG2A in HIV infection could also contribute to the
polyclonal activation which characterizes HIV infec-
tion.Retrovirology 2007, 4:72 http://www.retrovirology.com/content/4/1/72
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